
GIMS.dx is a platform to improve processes of any NGS-based molecular diagnostic: germline and somatic. This includes genetic diagnostics of rare hereditary diseases, cancer predispositions and sequencing analyses of tumor materials as well.
The core feature of GIMS.dx is our recently developed DNAwiz, that harbours structured step by step decision-making and doumentation-workflows for variant classification, clinical interpretation and recommendation.
With GIMS.dx physicians and scientists in genetics and pathology can do their important work in a structured ecosystem that is the basis for better medical decisions.
By using GIMS, molecular and clinical teams work together in a digital genetic ecosystem. The aggregated knowledge and findings become transparently trusted and disseminated: the fair sharing of variant information, genetic knowledge and clinical observations is part of a continuous truth-finding process.
Stepwise guidance through variant classification and interpretation process:
Structured documentation process with clear-cut workflows for review and approval processes:
PLEASE NOTE: By filling out the contact form and activating the send button you consent to the processing of the stated data according to art. 6, para. 1a EU-GDPR for the purpose of processing your inquiry. More information can be found in our privacy policy.